Press Releases
Biocon’s Breakthrough Drug Itolizumab Receives DCGI Nod for its Use in Moderate to Severe COVID-19 Patients
Biocon Ltd., an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb®) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome...
Press Releases
“CARGY”, the new digital solution partner by Turkish Cargo
Providing air cargo service to 127 countries worldwide, Turkish Cargo’s “CARGY”, the new artificial intelligence robot that provides customers with the opportunity to inquire the status of their cargo 24/7, goes live.
During its initial phase, Cargy, the artificial intelligence-based...
Press Releases
AbbVie : FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with Spasticity
Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX® for the treatment of spasticity in pediatric patients 2 years of age and older, including those with...
Press Releases
Aigenpulse introduces novel data intelligence platform to life science markets
Life science and data technology innovator, Aigenpulse,is introducing a new state of-the-art data intelligence platform which is designed to expedite the drug discovery and development process. The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to...
Drug Research
Vetter Further Expands its Development Service with New Site in Austria
With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further...
Press Releases
AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer
AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the EU for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer.
Pancreatic cancer is a rare, life-threatening disease with the lowest survival rate among the...
Press Releases
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system. CoVLPs mimic the structure of the virus responsible for COVID-19 disease, allowing them...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read